FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease" is generating significant coverage in the Business category, with 3 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Bloomberg.com, ABC News - Breaking News, Latest News and Videos and Axios. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 48d ago.
Quick answers
Why is "FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Dis" trending?
Because 3 independent news sources published 3 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (15)
- The Race to Develop More Medicines Like the New Pancreatic Cancer Drug The New York Times · 48d ago
- FDA approves landmark pancreatic cancer drug that's shown to improve survival NPR · 48d ago
- Pancreatic cancer drug approved by FDA is "exceptional moment," Boston researcher says CBS News · 48d ago
- Revolution’s pancreatic cancer drug wins speedy FDA approval CNN · 48d ago
- FDA approves breakthrough drug to treat advanced pancreatic cancer ABC11 News · 48d ago
- Opinion WSJ · 48d ago
- U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease Scientific American · 48d ago
- FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Fox News · 48d ago
- Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters · 48d ago
- FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results Forbes · 48d ago
- FDA approves pancreatic cancer drug that extends patients’ lives The Washington Post · 48d ago
- US approves new treatment for pancreatic cancer Le Monde.fr · 48d ago
- A Breakthrough Pancreatic Cancer Drug Marks a New Era for Treatment Bloomberg.com · 48d ago
- FDA approves breakthrough drug to treat advanced pancreatic cancer ABC News - Breaking News, Latest News and Videos · 48d ago
- A major RAS drug milestone could spur interest in rival assets Axios · 48d ago
Topics
Related trends
These common infections can cause cancer. Here’s what can lower your risk.
Recent coverage highlights a significant global link between common infections and millions of new cancer diagnoses.
Leo XIV’s Cancer Diagnosis Tests the Assumption of a Long Papacy
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
The National Institutes of Health launches a major public-private partnership focused on advancing cancer vaccines.
FDA-Approved Drug Could Be Repurposed to Relieve Osteoarthritis Pain And Protect Cartilage
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Two deaths were reported to the FDA. Is the bootleg weight-loss drug "Reta" to blame?
Federal regulators face mounting scrutiny as unapproved weight-loss drugs and new safety warnings enter public focus.
Baby sleep product recalled after FDA finds 3 types of alcohol not listed on label
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.